EUVIMEDEUVIMED entdecken
Crossref

Drug-eluting vascular stents with surface modification of anticoagulation and pro-endothelialization

Mengdi Liang, Dulin Zuo, Feng Wang, Bei Zhang, Jingjing Tian, Xianchen Huang, Yuan Sun, Guanqiang Li, Xicheng Zhang, Gang Li iD

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.5c01382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Mengdi Liang und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for Modern Silk, College of Textile and Clothing Engineering, Soochow University, Suzhou 215123, China. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Anticoagulants, Heparin, Coated Materials, Biocompatible. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Key Research and Development Program of China, Jiangsu Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) treatment relies on covered stents, yet thrombosis, restenosis, and delayed endothelialization remain challenges. This study developed a bifunctional heparin/zwitterionic polymer (CBMA) coating on dopamine-modified stents via surface-initiated atom transfer radical polymerization (SI-ATRP). The coating integrates CBMA’s antifouling properties (98.5% reduction in BSA adsorption) with heparin’s sustained anticoagulation (37% APTT prolongation, 17 s TT increase) and endothelialization promotion (194.97% endothelial cell activity after 5 days). Animal trials confirmed reduced TNF-α expression (75% decrease), enhanced collagen deposition, neovascularization post-28 days, and preserved mechanical strength (diametral tensile strength >57 MPa) with 25% lower permeability. This dual-functional coating offers a novel synergistic strategy for antithrombosis and endothelial repair in clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsAnticoagulantsHeparinCoated Materials, BiocompatibleAnimalsHumansSurface PropertiesAortic Aneurysm, AbdominalPolymersHuman Umbilical Vein Endothelial CellsMale

Substanzen

AnticoagulantsHeparinCoated Materials, BiocompatiblePolymers

Autor:innen und Institutionen

  • National Engineering Laboratory for Modern Silk, College of Textile and Clothing Engineering, Soochow University, Suzhou 215123, China.
  • Department of Vascular Surgery, The Fourth Affiliated Hospital of Soochow University, Suzhou 215000, China.

ORCID-Profile: Gang Li

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • National Key Research and Development Program of China
  • Jiangsu Provincial Department of Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Liang, M., Zuo, D., Wang, F., Zhang, B., Tian, J., Huang, X., Sun, Y., Li, G., Zhang, X., & Li, G. (2025). Drug-eluting vascular stents with surface modification of anticoagulation and pro-endothelialization. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c01382

Vancouver

Liang M, Zuo D, Wang F, Zhang B, Tian J, Huang X, et al. Drug-eluting vascular stents with surface modification of anticoagulation and pro-endothelialization. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c01382

BibTeX
@article{Liang2025,
  author = {Liang, Mengdi and Zuo, Dulin and Wang, Feng and Zhang, Bei and Tian, Jingjing and Huang, Xianchen and Sun, Yuan and Li, Guanqiang and Zhang, Xicheng and Li, Gang},
  title = {Drug-eluting vascular stents with surface modification of anticoagulation and pro-endothelialization},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.5c01382}
}
Kostenlos starten →